Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Language
Publication year range
1.
Cureus ; 13(6): e15660, 2021 Jun.
Article in English | MEDLINE | ID: mdl-34277253

ABSTRACT

Fusobacterium nucleatum may be implicated in cases of emphysematous cholecystitis (EC) and carries a high mortality risk, especially in individuals with heart disease, renal insufficiency, and underlying malignancy. Fusobacterium infections are rarely detected in the setting of cholecystitis possibly due to the difficulty with properly culturing the bacteria. We describe a case of a patient with EC in whom blood cultures were positive for growth of F. nucleatum in one of two samples. The patient was treated with empiric antibiotic therapy consisting of metronidazole and cefepime. In patients with EC and negative cultures, it is possible that they may have an undetected infection with fusobacteria, which carries a high mortality risk. As such, clinicians should maintain a high degree of suspicion of obligate anaerobic infection in patients who have negative blood culture for growth in the setting of EC and consider continuation of adequate antimicrobial coverage.

2.
Cureus ; 12(9): e10195, 2020 Sep 02.
Article in English | MEDLINE | ID: mdl-33033673

ABSTRACT

Posterior reversible encephalopathy syndrome (PRES) is a syndrome presenting with neurological manifestations including headaches, seizures, and notable changes in brain imaging. It is typically associated with an acute increase in blood pressure, metabolic abnormalities, and/or medication effects. PRES is challenging to diagnose due to its variable presentation and low incidence. Herein we describe a compelling case of PRES syndrome secondary to uncontrolled hypertension in the setting of systemic lupus erythematosus (SLE) and lupus nephritis.

3.
J Investig Med High Impact Case Rep ; 8: 2324709620960001, 2020.
Article in English | MEDLINE | ID: mdl-32935586

ABSTRACT

Acute myocardial infarction (AMI) is a rare but recognized and potentially serious complication of infective endocarditis (IE). This case describes the challenges surrounding the management of AMI in the setting of septic coronary embolism, brain, spleen, and kidney infarcts due to septic emboli from native mitral valve IE.


Subject(s)
Embolism/etiology , Endocarditis/complications , Myocardial Infarction/etiology , Coronary Angiography , Coronary Artery Bypass , Disease Management , Embolism/diagnostic imaging , Embolism/surgery , Endocarditis/diagnostic imaging , Endocarditis/surgery , Female , Heart Valve Prosthesis Implantation , Humans , Middle Aged , Mitral Valve , Myocardial Infarction/diagnostic imaging , Myocardial Infarction/surgery
4.
J Investig Med High Impact Case Rep ; 8: 2324709620938228, 2020.
Article in English | MEDLINE | ID: mdl-32602372

ABSTRACT

Nocardia brasiliensis is the most common cause of cutaneous nocardiosis. Nocardia pseudobrasiliensis is an emerging species responsible for invasive and disseminated disease in immunocompromised patients. We describe a case of a 67-year-old immunocompetent patient without significant past medical history diagnosed with primary cutaneous nocardiosis with N pseudobrasiliensis as the causative organism. In our opinion, we report the first case of primary cutaneous nocardiosis in an immunocompetent patient with N pseudobrasiliensis being the causative agent.


Subject(s)
Nocardia Infections/diagnosis , Nocardia/isolation & purification , Skin Diseases, Bacterial/microbiology , Aged , Anti-Infective Agents/therapeutic use , Diagnosis, Differential , Female , Humans , Immunocompetence , Nocardia Infections/drug therapy , Nocardia Infections/microbiology , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/drug therapy , Sulfamethoxazole/therapeutic use , Trimethoprim/therapeutic use
5.
BMJ Case Rep ; 20162016 Feb 22.
Article in English | MEDLINE | ID: mdl-26903365

ABSTRACT

This is a case of a 63-year-old, post total colectomy patient, who presented to the hospital with watery diarrhoea, abdominal cramping and fevers. On admission, the patient was haemodynamically stable and febrile. Clostridium difficile PCR was sent and tested positive. CT of the abdomen revealed diffuse thickening of the distal small bowel to the level of the anastomosis and mesenteric oedema consistent with infectious enteritis. The patient was started on vancomycin orally as well as flagyl intravenously. Because of an ileus, he initially was treated with bowel rest and a NG tube. Surgical consult was obtained early with no intervention. The patient's symptoms progressively resolved over the next 7 days of hospitalisation, and he was discharged home.


Subject(s)
Enterocolitis, Pseudomembranous/diagnostic imaging , Ileitis/diagnostic imaging , Adenocarcinoma/surgery , Anti-Bacterial Agents/therapeutic use , Bacterial Proteins/genetics , Bacterial Toxins/genetics , Clostridioides difficile/genetics , Colectomy , Colonic Neoplasms/surgery , Enterocolitis, Pseudomembranous/diagnosis , Enterocolitis, Pseudomembranous/drug therapy , Humans , Ileitis/diagnosis , Ileitis/drug therapy , Male , Middle Aged , Polymerase Chain Reaction , Tomography, X-Ray Computed , Vancomycin/therapeutic use
6.
Folia Histochem Cytobiol ; 50(1): 125-9, 2012 Apr 24.
Article in English | MEDLINE | ID: mdl-22532147

ABSTRACT

Docosahexaenoic acid (DHA) potentially modulates inflammatory processes. Therefore, the aim of this study was to determine the influence of DHA supplementation on the expression of intestinal inflammation and nutritional status in rats which have undergone restorative proctocolectomy. Twenty-four Wistar rats were operated. After the induction of pouchitis, animals were randomly divided into a control group (CG) and supplementation groups receiving respectively a semi-synthetic diet without or with DHA (in a lower or higher dose, respectively known as the lower dose, LD, and higher dose, HD, groups) for six weeks. Selected nutritional parameters were assessed. Histopathological and immunohistochemical analysis of pouch mucosa specimens was also performed. The effectiveness of feeding and quality of stools were significantly better in the HD group than in the CG. The intensity of inflammation (Moskovitz scale) was higher in HD and LD than in CG (p = 0.03 and p = 0.0006, respectively). Nevertheless, pouch adaptation (Laumonier scale) was more significant in LD than in CG (p = 0.007). On the other hand, tissue expression of IL-1α and IL-10 was higher in HD and LD than in CG (IL-1α, p = 0.009 and p = 0.05, respectively; IL-10, p = 0.04 for both). DHA supplementation has no impact on body weight gain. Yet it seems that it may improve the effectiveness of nutrition and stool quality in rats which have undergone restorative proctocolectomy. Simultaneously, it increases the intensity of pouch adaptation and inflammation. The specificity of observed changes is not clear. However, it may imply potential modulation of inflammatory processes of pouch mucosa.


Subject(s)
Dietary Supplements , Disease Models, Animal , Docosahexaenoic Acids/therapeutic use , Pouchitis/diet therapy , Animals , Docosahexaenoic Acids/administration & dosage , Inflammation/diet therapy , Inflammation/pathology , Pouchitis/pathology , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL